First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality

BMC Research Notes

Volumn 8, Issue 1, 2015, Pages

  Fogarty, Gerald B ^a,b,c,d,j   Hong, Angela ^a,d,e   Dolven Jacobsen, Kari ^g   Reisse, Claudius H ^g   Burmeister, Bryan ^d,h,j   Haydu, Lauren H ^a   Dhillon, Haryana ^e,i   Steel, Victoria ^j   Shivalingam, Brindha ^f   Drummond, Kate ^k   Vardy, Janette ^e,i,n   Nowak, Anna ^l,m   Hruby, George ^e,f,j   Scolyer, Richard A ^a,e,f   Mandel, Catherine ^k   Thompson, John F ^a,e,f,j  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c Mater Hospital   (Australia)

^d Trans Tasman Radiation Oncology Group   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h PRINCESS ALEXANDRA HOSPITAL   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j Australia and New Zealand Gynaecological Oncology Group   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^m SIR CHARLES GAIRDNER HOSPITAL   (Australia)

ⁿ Department of Microbiology and Infectious Diseases   (Australia)

more..

Author keywords

Brain; Melanoma; Metastases; Radiotherapy; Randomised trial; Whole brain radiotherapy

Indexed keywords

ADULT; ADVERSE EFFECTS; AGED; BIOASSAY; BRAIN NEOPLASMS; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; MALE; MEASUREMENT ACCURACY; MELANOMA; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DATA ACCURACY; DEMOGRAPHY; DISEASE PROGRESSION; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; RADIOTHERAPY;

EID: 84929159985     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-015-1153-5     Document Type: Article

References (13)

1. De la Monte SM, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res. 1983;43:3427-33.
2. Sampson JH, Carter JH, Friedman AH, Seigler B. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88:11-20.
3. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004;22:1293-300.
4. Nicholas S, Mathios D, Jackson C, Lim M. Metastatic melanoma to the brain: surgery and radiation is still the standard of care. Curr Treat Options Oncol. 2013;14(2):264-79.
5. Windsor AA, Koh ES, Allen S, Gabriel GS, Yeo AE, Allison R, et al. Poor outcomes after whole brain radiotherapy in patients with brain metastases: results from an international multicentre cohort study. Clin Oncol (R Coll Radiol). 2013;25(11):674-80.
6. Thompson JF, Hong A, Fogarty G. Letter: publication and interpretation of clinical trial results: the need for caution. Ann Surg Oncol. 2012;19(6):1745-7.
7. Fogarty G, Morton RL, Vardy J, Nowak AK, Mandel C, Forder PM, et al. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients-a randomised phase III trial. BMC Cancer. 2011;11:142.
8. Fogarty GB, Hong A, Dolven Jacobsen K, Reisse CH, Shivalingam B, Burmeister B, et al. Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. BMC Research Notes. 2014;7:412.
9. Dyer MA, Arvold ND, Chen Y, Pinnell NE, Mitin T, Lee EQ, et al. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiat Oncol. 2014;9:143.
10. Soffietti R, Kocher M, Abacioglu U, Villa S, Fauchon F, Baumert B, et al. A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results. J Clin Oncol. 2013;31:65-72.
11. Slotman BJ, Mauer ME, Bottomley A, Faivre-Finn C, Kramer GWPM, Rankin EM, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms - results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol. 2009;27:78-84.
12. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DH, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10:1037-44.
13. Peters LJ, O'Sullivan B, Giralt J, Fitzgerald TJ, Trotti A, Bernier J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol. 2010;28((18):2996-3001.